Progress in Cardiovascular Diseases
Volume 53, Issue 1 , Pages 15-20, July 2010

From Framingham to North Karelia:

From Descriptive Epidemiology to Public Health Action

  • Pekka Puska

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Pekka Puska, MD, PhD, MPolSc, National Institute for Health and Welfare (THL) P.O. Box 30, FI-00271 Helsinki, Finland.

National Institute for Health and Welfare (THL) P.O. Box 30, FI-00271 Helsinki, Finland

Abstract 

The Framingham study was a landmark study that, already in the 1960s, gave strong evidence as to the likely causal role of several lifestyle-linked factors in the development of cardiovascular diseases (CVDs). Men in Finland had at that time the highest mortality rates of coronary heart disease in the world, a finding that raised much local concern. In 1972, a pioneering project by a young leadership team and with many partners, including World Health Organization, was started to change the situation. The project was based on the results for Framingham and some other classical studies to carry out a comprehensive prevention program to reduce the risk factor levels in the population through general lifestyle changes in the pilot area of North Karelia. Later on, the work was transferred to national level. Over the years, great reductions in the population levels of the risk factors took place, associated with dramatic reduction in age-adjusted CVD mortality rates and improvement in public health. The experience of diminishing the prevalence of risk factors in the population is a powerful demonstration of how the CVD epidemic can be successfully confronted—thatis, how the Framingham results can effectively be used for major progress in public health.

Abbreviations: CVD, cardiovascular disease, CHD, Coronary heart disease, WHO, World Health Organization

Keywords: Cardiovascular, Prevention, Risk factors, Public health

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Statement of Conflict of Interest: see page 20.

PII: S0033-0620(10)00004-6

doi:10.1016/j.pcad.2010.01.003

Progress in Cardiovascular Diseases
Volume 53, Issue 1 , Pages 15-20, July 2010